NCT06332079 2026-01-05
HAITI
Gruppo Oncologico del Nord-Ovest
Phase 2 Terminated
Clinical Trials
34 trialsNCT06540326 2025-12-22
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT06764680 2025-08-24
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT07061210 2025-07-11
An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer
Fudan University
Phase 2 Not yet recruiting
NCT07044921 2025-07-01
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
Chinese PLA General Hospital
Phase 2 Recruiting
NCT04730544 2025-06-13
NIPISAFE
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Active not recruiting
NCT07007767 2025-06-06
Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting
NCT05727163 2025-05-30
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Sun Yat-sen University
Phase 2 Recruiting
NCT06973343 2025-05-15
Sintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver Metastasis
Anhui Provincial Cancer Hospital
Phase 2 Not yet recruiting
NCT06959589 2025-05-06
The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT05243862 2025-03-18
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Treos Bio Limited
Phase 2 Active not recruiting
NCT06282445 2025-02-17
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2 Recruiting
NCT06685276 2024-11-20
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
Chinese PLA General Hospital
Phase 2 Recruiting
NCT06679673 2024-11-07
SHR-1701 Combined with SHR2554 and BP102 for MCRC
Fudan University
Phase 2 Not yet recruiting
NCT05584137 2024-10-15
Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC
Shanghai Henlius Biotech
Phase 2 Terminated
NCT03164655 2024-10-01
SULTAN
UNICANCER
Phase 2 Completed
NCT06440902 2024-06-04
Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
Fudan University
Phase 2 Recruiting
NCT05092880 2023-12-19
CAIRO7
UMC Utrecht
Phase 2 Recruiting
NCT04262687 2023-08-18
POCHI
Federation Francophone de Cancerologie Digestive
Phase 2 Unknown
NCT04169347 2023-07-27
FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Criterium, Inc.
Phase 2 Unknown
NCT04030260 2023-03-23
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT03251612 2023-01-18
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
Vejle Hospital
Phase 2 Completed
NCT05062720 2022-12-09
Local Consolidative Therapy in Colorectal Cancer
Fox Chase Cancer Center
Phase 2 Withdrawn
NCT03167268 2021-09-09
PaSTo
Ospedale San Carlo Borromeo
Phase 2 Unknown
NCT03751176 2021-06-30
BEYOND
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2 Unknown
NCT04888806 2021-05-17
A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis
Harbin Medical University
Phase 2 Unknown
NCT03898102 2019-04-01
ZnCORRECT
Chang Gung Memorial Hospital
Phase 2 Completed
NCT03792269 2019-01-03
Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT03705442 2018-10-15
Probat-tmcc-17
University Hospital Rijeka
Phase 2 Unknown
NCT01882868 2017-03-14
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Sanofi
Phase 2 Completed
NCT01522612 2016-06-10
Colorectal Cancer (CRC) Cetuximab Elderly Frail
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT01668680 2015-07-08
Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma
HaEmek Medical Center, Israel
Phase 2 Terminated
NCT01909830 2015-06-19
Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT02085005 2014-11-18
Drop and Go
Sanofi
Phase 2 Withdrawn